| Name | Title | Contact Details |
|---|
Technology and innovation is constantly changing the way consumers interact with each other and businesses. When we first started talking about Laybuy we identified two problems we were trying to solve. The first is a problem common to all consumers...
WordPress - Blogging software with style.
Explore the universe of Zadig&Voltaire: the latest collection, fragrances, accessories.
Lancium is a technology company creating software and technical solutions that enable the faster growth of renewable energy.
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.